Recently, studies have shown the interest of NfL measurement in CSF (Abu-Rumeileh and Parchi, 2021) and in blood (Schmitz et al., 2022) to help in the early diagnosis of the disease and to differentiate it from other causes of dementia, in particular from progressive forms of AD. Here, NEFL is linked to dementia.